DUBLIN–(BUSINESS WIRE)–The “Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th – Apr 30th, 2026)” training has been added to ResearchAndMarketsDUBLIN–(BUSINESS WIRE)–The “Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th – Apr 30th, 2026)” training has been added to ResearchAndMarkets

Understanding Active Pharmaceutical Ingredients (APIs): Online Training Course (Apr 29-30, 2026) – Enhance Your API Expertise with In-Depth GMP and GDP Training – ResearchAndMarkets.com

2026/01/22 03:32
Okuma süresi: 3 dk

DUBLIN–(BUSINESS WIRE)–The “Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th – Apr 30th, 2026)” training has been added to ResearchAndMarkets.com’s offering.

An active pharmaceutical ingredient (API) or drug substance is any substance or mixture of substances intended to be used in the manufacture of a medicinal product, which is intended to furnish pharmacological activity, or have another direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or affect the structure and function of the body.

This course has been designed to provide attendees with a fundamental understanding of best practice and the regulatory environment applicable to active pharmaceutical ingredients in the pharmaceutical industry. It will cover key terminology, the EU and USA regulatory framework, Good Manufacturing Practice (GMP) requirements including controls and validation, and consider Good Distribution Practice (GDP) and how to manage your supply chain. Practical exercises will form part of the course to aid the learning process.

This is an essential and valuable introduction to the manufacture of APIs.

Benefits of Attending:

  • Gain a comprehensive overview of the API regulatory framework
  • Enhance your understanding of the key terms used in API manufacture
  • Recognise how Good Manufacturing Practices (GMP) apply to API synthesis
  • Understand the different approaches between small-molecule and large molecule processing
  • Learn how to manage the risk associated with your supply chain

Who Should Attend:

  • New entrants to those individuals working in a GxP environment
  • Quality management manufacturing specialists
  • Regulatory compliance specialists
  • Pharmaceutical technical professionals
  • Pharmaceutical professionals looking to enhance their Continuous Professional Development (CPD)

Agenda: Day 1

Introduction to APIs

  • Terminology and acronyms
  • Globalisation
  • Introduction to the regulatory framework

Methods and equipment – Part 1

  • Chemical synthesis
  • Reactors
  • Isolation
  • Drying
  • Exercise: managing particle size

Methods and equipment – Part 2

  • Biological
  • Fermentation
  • Harvesting
  • Exercise: impurities

Good Manufacturing Practice (GMP)

  • Requirements
  • Regulations
  • EU
  • FDA
  • Exercise: similarities and differences

GMP requirements (continued)

  • Pharmaceutical Quality System
  • Validation and Qualification
  • Outsourcing
  • Exercise: specialist or generalist

Supply chain considerations

  • Falsified Medicines Directive (FMD)
  • Good Distribution Practice (GDP) for APIs
  • Exercise risk mitigation

Agenda: Day 2

Introduction and recap

Registration aspects of production and control

  • The registration process
  • The Common Technical Document (CTD)
  • Active substance/drug master files
  • Exercise: strategy

Laboratory controls

  • Good Quality Control Laboratory Practice (GQCLP)
  • Validation
  • Stability
  • Exercise: data Integrity

Process validation

  • Purpose of validation
  • General considerations
  • Exercise: critical attributes

Cleaning validation

  • Cleaning strategy
  • Key requirements
  • Residues
  • Exercise: purpose

API control packaging materials

  • What to consider
  • Data requirements
  • Extraction, interaction, migration and sorption
  • Toxicology
  • Exercise: environmental factors

Wrap up and Q&A

For more information about this training visit https://www.researchandmarkets.com/r/ydcok1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Piyasa Fırsatı
aPriori Logosu
aPriori Fiyatı(APR)
$0.08517
$0.08517$0.08517
+3.28%
USD
aPriori (APR) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Fan Token Firm Chiliz Acquires 2-Time ‘Dota 2’ Champions, OG Esports

Fan Token Firm Chiliz Acquires 2-Time ‘Dota 2’ Champions, OG Esports

The post Fan Token Firm Chiliz Acquires 2-Time ‘Dota 2’ Champions, OG Esports appeared on BitcoinEthereumNews.com. In brief The Chiliz Group has acquired a controlling stake in OG Esports, a prominent competitive gaming organization. OG Esports unveiled its own fan token on Chiliz’s Socios.com platform back in 2020. It recently hit an all-time high price. Chiliz has teased various future team-related benefits for OG token holders, along with a new Web3-related project. The Chiliz Group, which operates the Socios.com crypto fan token platform, announced Tuesday that it has acquired a 51% controlling stake in OG Esports, the competitive gaming organization founded in 2015 by Dota 2 legends Johan “nOtail” Sundstein and Sébastien “Ceb” Debs. OG made history as the first team to win consecutive titles at The International—the annual, high-profile Dota 2 world championship tournament—in 2018 and 2019, and has since expanded into multiple games including Counter-Strike, Honor of Kings, and Marvel Rivals. The team was also the first esports organization to join the Socios platform with the 2020 debut of its own fan token, which Chiliz said recently became the first esports team token to exceed a $100 million market capitalization. OG was recently priced at $16.88, up nearly 9% on the day following the announcement. The token’s price peaked at a new all-time high of $24.78 last week ahead of The International 2025, where OG did not compete this year. Following the acquisition, Xavier Oswald will assume the CEO role, while the co-founders will turn their attention to “a new strategic project consolidating the team’s competitive foundation [and] driving innovation at the intersection of esports and Web3,” per a press release. No further details were provided regarding that project. “Bringing OG into the Chiliz Group is a major step toward further strengthening fan experiences, one where the community doesn’t just watch from the sidelines but gets to shape the journey,” Chiliz CEO Alex Dreyfus…
Paylaş
BitcoinEthereumNews2025/09/18 09:40
Travelzoo Q4 2025 Earnings Conference Call on February 19 at 11:00 AM ET

Travelzoo Q4 2025 Earnings Conference Call on February 19 at 11:00 AM ET

NEW YORK, Feb. 9, 2026 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO): WHAT: Travelzoo, the club for travel enthusiasts, will host a conference call to discuss the Company
Paylaş
AI Journal2026/02/10 01:46
Trump Backs Bitcoin As New Safe Haven

Trump Backs Bitcoin As New Safe Haven

On CNBC, Eric Trump stated that Bitcoin has "taken the role of gold in today’s world," elevating crypto to the status of a strategic safe haven asset. This media appearance coincides with the launch of American Bitcoin, a mining and BTC holding company he is close to. Far from a mere announcement, this statement fits within a dynamic where publicly traded companies are beginning to integrate bitcoin at the heart of their reserve strategy. L’article Trump Backs Bitcoin As New Safe Haven est apparu en premier sur Cointribune.
Paylaş
Coinstats2025/09/18 14:32